aluates Reports

$ 0.0

Automative

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-15V14018

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2023

BUY CHAPTERS

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2025

Code: QYRE-Auto-15V14018

Report

March 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Tianjin Angsai Cell Genetic Engineering Co. Ltd

Qingdao Aoke Biological Development Co. Ltd

Beijing SH biotechnology Co. Ltd

Beijing Beilai Biotechnology Co. Ltd

Shanghai Aisar Biotechnology Co. Ltd

Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd

Bosheng Excellence Biotechnology (Beijing) Co. Ltd

Cellular Biomedicine Group

Guangzhou Celera Stem Cell Technology Co. Ltd.

Stem Med Pte Ltd

CryoCord Sdn Bhd

Cytopeutics Sdn Bhd

Stempeutics Research Pvt. Ltd.

Asian Institute of Gastroenterology

Beijing Han's United Biotechnology Co. Ltd

Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size

The global market for Msenchymal Stem Cell and Exosome Diagnostics and Therapies was valued at US$ 125 million in the year 2024 and is projected to reach a revised size of US$ 678 million by 2031, growing at a CAGR of 27.7% during the forecast period.

Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market

Exosomes are a type of vesicles (Extracellular Vesicles, EVs) secreted by cells to the outside of the cell, with a size of 30-150nm, a double-layer membrane structure and a saucer-like shape, and rich contents (including nucleic acids, proteins and lipids, etc.), involved in the transfer of molecules between cells. As an emerging technology, it has many problems, including accurately encoding and delivering targeted therapeutics, not to mention issues surrounding intellectual property and large-scale manufacturing. For diagnostic applications, products from Exosome Diagnostics are available; for therapeutic applications, although there are three listed companies focusing on exosomes - Capricor, Puretech and Reneuron, none of the company's products have actually been used in clinical practice.

Exosome industry in China is in the initial stage of germination and development, The exosome industry in foreign currently has a limited number of players. Geographically speaking, China holds about 80% of total market share.

This report aims to provide a comprehensive presentation of the global market for Msenchymal Stem Cell and Exosome Diagnostics and Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Msenchymal Stem Cell and Exosome Diagnostics and Therapies.

The Msenchymal Stem Cell and Exosome Diagnostics and Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Report

Report Metric	Details
Report Name	Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market
Accounted market size in year	US$ 125 million
Forecasted market size in 2031	US$ 678 million
CAGR	27.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Type I Type II
Segment by Application	Diagnostics Therapies Skincare
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Tianjin Angsai Cell Genetic Engineering Co. Ltd, Qingdao Aoke Biological Development Co. Ltd, Beijing SH biotechnology Co. Ltd, Beijing Beilai Biotechnology Co. Ltd, Shanghai Aisar Biotechnology Co. Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Beijing Han's United Biotechnology Co. Ltd, Bosheng Excellence Biotechnology (Beijing) Co. Ltd, Cellular Biomedicine Group, Guangzhou Celera Stem Cell Technology Co. Ltd., Stem Med Pte Ltd, CryoCord Sdn Bhd, Cytopeutics Sdn Bhd, Stempeutics Research Pvt Ltd, Asian Institute of Gastroenterology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Msenchymal Stem Cell and Exosome Diagnostics and Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market growing?

Ans: The Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market witnessing a CAGR of 27.7% during the forecast period 2025-2031.

What is the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market size in 2031?

Ans: The Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market size in 2031 will be US$ 678 million.

What is the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market share by region?

Ans: Geographically speaking, China holds about 80% of total market share.

Who are the main players in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report?

Ans: The main players in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market are Tianjin Angsai Cell Genetic Engineering Co. Ltd, Qingdao Aoke Biological Development Co. Ltd, Beijing SH biotechnology Co. Ltd, Beijing Beilai Biotechnology Co. Ltd, Shanghai Aisar Biotechnology Co. Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Beijing Han's United Biotechnology Co. Ltd, Bosheng Excellence Biotechnology (Beijing) Co. Ltd, Cellular Biomedicine Group, Guangzhou Celera Stem Cell Technology Co. Ltd., Stem Med Pte Ltd, CryoCord Sdn Bhd, Cytopeutics Sdn Bhd, Stempeutics Research Pvt Ltd, Asian Institute of Gastroenterology

What are the Application segmentation covered in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report?

Ans: The Applications covered in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report are Diagnostics, Therapies, Skincare

What are the Type segmentation covered in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report?

Ans: The Types covered in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report are Type I, Type II

Recommended Reports

Exosome Technologies

Stem Cell Therapies

Regenerative Medicine

Market trends :

Topic	Trends
Global	the global mesenchymal stem cell and exosome diagnostics and therapies market is experiencing rapid growth driven by technological advancements, rising demand for regenerative medicine, and increased focus on exosome-based diagnostics and therapies.
Region	APAC - china dominates the global market with approximately 80% share, reflecting strong domestic investment and early-stage development in exosome and stem cell technologies.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Type I

1.2.3 Type II

1.3 Market by Application

1.3.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Diagnostics

1.3.3 Therapies

1.3.4 Skincare

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Perspective (2020-2031)

2.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Growth Trends by Region

2.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Region (2020-2025)

2.2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (2026-2031)

2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Dynamics

2.3.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Trends

2.3.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers

2.3.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Challenges

2.3.4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue

3.1.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue (2020-2025)

3.1.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Players (2020-2025)

3.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue

3.4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Concentration Ratio

3.4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2024

3.5 Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies Head office and Area Served

3.6 Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Product and Application

3.7 Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Type

4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Type (2020-2025)

4.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (2026-2031)

5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Application

5.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Application (2020-2025)

5.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2020-2031)

6.2 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2020-2025)

6.4 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2020-2031)

7.2 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2020-2025)

7.4 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2020-2031)

8.2 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2020-2025)

8.4 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2020-2031)

9.2 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2020-2025)

9.4 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2020-2031)

10.2 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2020-2025)

10.4 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd

11.1.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Details

11.1.2 Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview

11.1.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.1.4 Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.1.5 Tianjin Angsai Cell Genetic Engineering Co. Ltd Recent Development

11.2 Qingdao Aoke Biological Development Co. Ltd

11.2.1 Qingdao Aoke Biological Development Co. Ltd Company Details

11.2.2 Qingdao Aoke Biological Development Co. Ltd Business Overview

11.2.3 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.2.4 Qingdao Aoke Biological Development Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.2.5 Qingdao Aoke Biological Development Co. Ltd Recent Development

11.3 Beijing SH biotechnology Co. Ltd

11.3.1 Beijing SH biotechnology Co. Ltd Company Details

11.3.2 Beijing SH biotechnology Co. Ltd Business Overview

11.3.3 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.3.4 Beijing SH biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.3.5 Beijing SH biotechnology Co. Ltd Recent Development

11.4 Beijing Beilai Biotechnology Co. Ltd

11.4.1 Beijing Beilai Biotechnology Co. Ltd Company Details

11.4.2 Beijing Beilai Biotechnology Co. Ltd Business Overview

11.4.3 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.4.4 Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.4.5 Beijing Beilai Biotechnology Co. Ltd Recent Development

11.5 Shanghai Aisar Biotechnology Co. Ltd

11.5.1 Shanghai Aisar Biotechnology Co. Ltd Company Details

11.5.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview

11.5.3 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.5.4 Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.5.5 Shanghai Aisar Biotechnology Co. Ltd Recent Development

11.6 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd

11.6.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Details

11.6.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview

11.6.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.6.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.6.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Development

11.7 Beijing Han's United Biotechnology Co. Ltd

11.7.1 Beijing Han's United Biotechnology Co. Ltd Company Details

11.7.2 Beijing Han's United Biotechnology Co. Ltd Business Overview

11.7.3 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.7.4 Beijing Han's United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.7.5 Beijing Han's United Biotechnology Co. Ltd Recent Development

11.8 Bosheng Excellence Biotechnology (Beijing) Co. Ltd

11.8.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Details

11.8.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview

11.8.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.8.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.8.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Development

11.9 Cellular Biomedicine Group

11.9.1 Cellular Biomedicine Group Company Details

11.9.2 Cellular Biomedicine Group Business Overview

11.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.9.4 Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.9.5 Cellular Biomedicine Group Recent Development

11.10 Guangzhou Celera Stem Cell Technology Co. Ltd.

11.10.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Company Details

11.10.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview

11.10.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.10.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.10.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Development

11.11 Stem Med Pte Ltd

11.11.1 Stem Med Pte Ltd Company Details

11.11.2 Stem Med Pte Ltd Business Overview

11.11.3 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.11.4 Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.11.5 Stem Med Pte Ltd Recent Development

11.12 CryoCord Sdn Bhd

11.12.1 CryoCord Sdn Bhd Company Details

11.12.2 CryoCord Sdn Bhd Business Overview

11.12.3 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.12.4 CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.12.5 CryoCord Sdn Bhd Recent Development

11.13 Cytopeutics Sdn Bhd

11.13.1 Cytopeutics Sdn Bhd Company Details

11.13.2 Cytopeutics Sdn Bhd Business Overview

11.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.13.4 Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.13.5 Cytopeutics Sdn Bhd Recent Development

11.14 Stempeutics Research Pvt Ltd

11.14.1 Stempeutics Research Pvt Ltd Company Details

11.14.2 Stempeutics Research Pvt Ltd Business Overview

11.14.3 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.14.4 Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.14.5 Stempeutics Research Pvt Ltd Recent Development

11.15 Asian Institute of Gastroenterology

11.15.1 Asian Institute of Gastroenterology Company Details

11.15.2 Asian Institute of Gastroenterology Business Overview

11.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.15.4 Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

11.15.5 Asian Institute of Gastroenterology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Tianjin Angsai Cell Genetic Engineering Co. Ltd

Qingdao Aoke Biological Development Co. Ltd

Beijing SH biotechnology Co. Ltd

Beijing Beilai Biotechnology Co. Ltd

Shanghai Aisar Biotechnology Co. Ltd

Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd

Bosheng Excellence Biotechnology (Beijing) Co. Ltd

Cellular Biomedicine Group

Guangzhou Celera Stem Cell Technology Co. Ltd.

Stem Med Pte Ltd

CryoCord Sdn Bhd

Cytopeutics Sdn Bhd

Stempeutics Research Pvt. Ltd.

Asian Institute of Gastroenterology

Beijing Han's United Biotechnology Co. Ltd

List of Tables

Table 1. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Type I

Table 3. Key Players of Type II

Table 4. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2020-2025)

Table 8. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2026-2031)

Table 10. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Trends

Table 11. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers

Table 12. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Challenges

Table 13. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints

Table 14. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Players (2020-2025)

Table 16. Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies as of 2024)

Table 17. Ranking of Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Headquarters and Area Served

Table 20. Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Product and Application

Table 21. Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Type (2020-2025)

Table 25. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Type (2026-2031)

Table 27. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Application (2020-2025)

Table 29. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Application (2026-2031)

Table 31. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 46. Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Details

Table 47. Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview

Table 48. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 49. Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 50. Tianjin Angsai Cell Genetic Engineering Co. Ltd Recent Development

Table 51. Qingdao Aoke Biological Development Co. Ltd Company Details

Table 52. Qingdao Aoke Biological Development Co. Ltd Business Overview

Table 53. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 54. Qingdao Aoke Biological Development Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 55. Qingdao Aoke Biological Development Co. Ltd Recent Development

Table 56. Beijing SH biotechnology Co. Ltd Company Details

Table 57. Beijing SH biotechnology Co. Ltd Business Overview

Table 58. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 59. Beijing SH biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 60. Beijing SH biotechnology Co. Ltd Recent Development

Table 61. Beijing Beilai Biotechnology Co. Ltd Company Details

Table 62. Beijing Beilai Biotechnology Co. Ltd Business Overview

Table 63. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 64. Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 65. Beijing Beilai Biotechnology Co. Ltd Recent Development

Table 66. Shanghai Aisar Biotechnology Co. Ltd Company Details

Table 67. Shanghai Aisar Biotechnology Co. Ltd Business Overview

Table 68. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 69. Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 70. Shanghai Aisar Biotechnology Co. Ltd Recent Development

Table 71. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Details

Table 72. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview

Table 73. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 74. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 75. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Development

Table 76. Beijing Han's United Biotechnology Co. Ltd Company Details

Table 77. Beijing Han's United Biotechnology Co. Ltd Business Overview

Table 78. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 79. Beijing Han's United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 80. Beijing Han's United Biotechnology Co. Ltd Recent Development

Table 81. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Details

Table 82. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview

Table 83. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 84. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 85. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Development

Table 86. Cellular Biomedicine Group Company Details

Table 87. Cellular Biomedicine Group Business Overview

Table 88. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 89. Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 90. Cellular Biomedicine Group Recent Development

Table 91. Guangzhou Celera Stem Cell Technology Co. Ltd. Company Details

Table 92. Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview

Table 93. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 94. Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 95. Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Development

Table 96. Stem Med Pte Ltd Company Details

Table 97. Stem Med Pte Ltd Business Overview

Table 98. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 99. Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 100. Stem Med Pte Ltd Recent Development

Table 101. CryoCord Sdn Bhd Company Details

Table 102. CryoCord Sdn Bhd Business Overview

Table 103. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 104. CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 105. CryoCord Sdn Bhd Recent Development

Table 106. Cytopeutics Sdn Bhd Company Details

Table 107. Cytopeutics Sdn Bhd Business Overview

Table 108. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 109. Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 110. Cytopeutics Sdn Bhd Recent Development

Table 111. Stempeutics Research Pvt Ltd Company Details

Table 112. Stempeutics Research Pvt Ltd Business Overview

Table 113. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 114. Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 115. Stempeutics Research Pvt Ltd Recent Development

Table 116. Asian Institute of Gastroenterology Company Details

Table 117. Asian Institute of Gastroenterology Business Overview

Table 118. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 119. Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025) & (US$ Million)

Table 120. Asian Institute of Gastroenterology Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Picture

Figure 2. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Type: 2024 VS 2031

Figure 4. Type I Features

Figure 5. Type II Features

Figure 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Application: 2024 VS 2031

Figure 8. Diagnostics Case Studies

Figure 9. Therapies Case Studies

Figure 10. Skincare Case Studies

Figure 11. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Report Years Considered

Figure 12. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region: 2024 VS 2031

Figure 15. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Players in 2024

Figure 16. Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2024

Figure 18. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2020-2031)

Figure 20. United States Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2020-2031)

Figure 24. Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2020-2031)

Figure 32. China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2020-2031)

Figure 40. Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2020-2031)

Figure 44. Turkey Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 48. Qingdao Aoke Biological Development Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 49. Beijing SH biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 50. Beijing Beilai Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 51. Shanghai Aisar Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 52. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 53. Beijing Han's United Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 54. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 55. Cellular Biomedicine Group Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 56. Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 57. Stem Med Pte Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 58. CryoCord Sdn Bhd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 59. Cytopeutics Sdn Bhd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 60. Stempeutics Research Pvt Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 61. Asian Institute of Gastroenterology Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)